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RESEARCH ARTICLE
Genome-wide identification of short 20,30-
cyclic phosphate-containing RNAs and their
regulation in aging
Megumi Shigematsu, Keisuke MorichikaID, Takuya Kawamura, Shozo Honda,
Yohei KirinoID*
Computational Medicine Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia,
Pennsylvania, United States of America
* Yohei.Kirino@jefferson.edu
Abstract
RNA molecules generated by ribonuclease cleavage sometimes harbor a 20,30-cyclic phos-
phate (cP) at their 30-ends. Those cP-containing RNAs (cP-RNAs) form a hidden layer of
transcriptome because standard RNA-seq cannot capture them as a result of cP’s preven-
tion of an adapter ligation reaction. Here we provide genome-wide analyses of short
cP-RNA transcriptome across multiple mouse tissues. Using cP-RNA-seq that can exclu-
sively sequence cP-RNAs, we identified numerous novel cP-RNA species which are mainly
derived from cytoplasmic tRNAs, mRNAs, and rRNAs. Determination of the processing
sites of substrate RNAs for cP-RNA generation revealed highly-specific RNA cleavage
events between cytidine and adenosine in cP-RNA biogenesis. cP-RNAs were not evenly
derived from the overall region of substrate RNAs but rather from specific sites, implying
that cP-RNAs are not from random degradation but are produced through a regulated bio-
genesis pathway. The identified cP-RNAs were abundantly accumulated in mouse tissues,
and the expression levels of cP-RNAs showed age-dependent reduction. These analyses of
cP-RNA transcriptome unravel a novel, abundant class of non-coding RNAs whose expres-
sion could have physiological roles.
Author summary
With the advent and evolution of next-generation sequencing technology, efforts to identify
and catalog the expressed RNA molecules have greatly advanced our understanding of RNA
biology. However, the current standard RNA-seq methods, particularly those targeting short
ncRNAs, do not fully capture all of the RNAs expressed but allow for some “escapers” to slip.
RNAs generated by ribonuclease cleavage sometimes harbor a 20,30-cyclic phosphate (cP) at
their 30-ends, and those cP-containing RNAs (cP-RNAs) are one such escaper that are not
ligated to a 30-adapter and thus uncaptured by standard RNA-seq. Although an increasing
number of studies has been suggesting their functional significances, cP-RNAs remained a
hidden component in the transcriptome, infrequently recognized and characterized. In this
study, we provide the first genome-wide analyses of short cP-RNA transcriptome across







Citation: Shigematsu M, Morichika K, Kawamura
T, Honda S, Kirino Y (2019) Genome-wide
identification of short 20,30-cyclic phosphate-
containing RNAs and their regulation in aging.
PLoS Genet 15(11): e1008469. https://doi.org/
10.1371/journal.pgen.1008469
Editor: Zissimos Mourelatos, University of
Pennsylvania School of Medicine, UNITED STATES
Received: January 23, 2019
Accepted: October 10, 2019
Published: November 13, 2019
Copyright: © 2019 Shigematsu et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The cP-RNA-seq
libraries are publically available at NCBI’s Sequence
Read Archive (accession No. SRR8164560,
SRR8164561, SRR8164562, SRR8164563,
SRR9651811, SRR9651812, SRR9651813, and
SRR9651814).
Funding: This study was supported by the National
Institutes of Health Grant (GM106047 and
AI130496, to YK), American Cancer Society
Research Scholar Grant (RSG-17-059-01-RMC, to
YK), The W.W. Smith Charitable Trust Grant
multiple mouse tissues. By using cP-RNA-seq technique that can specifically sequence
cP-RNAs, we identified numerous novel cP-RNA species which are mainly derived from
tRNAs, mRNAs, and rRNAs. cP-RNAs are generated by previously-uncharacterized, highly-
specific RNA cleavage events between cytidine and adenosine, which is regulated through
aging. These analyses of cP-RNA transcriptome unravel a novel, abundant class of non-cod-
ing RNAs whose expression could have physiological roles.
Introduction
Cells express immensely diverse species of RNA molecules that play essential roles in numer-
ous biological processes. With the advent of next-generation sequencing (NGS) technology,
efforts to identify the expressed RNA molecules have greatly advanced our understanding of
RNA biology [1]. Although NGS-based RNA-sequencing (RNA-seq) has become a ubiquitous
tool in biological and medical research [2,3], the current standard RNA-seq methods, particu-
larly those targeting short non-coding RNAs (ncRNAs), do not fully capture all of the RNAs
expressed but allow for some “escapers” to slip by undetected. The RNAs containing a 20,30-
cyclic phosphate (cP) at their 30-end are one such escaper that are not ligated to a 30-adapter
during cDNA amplification procedure and thus uncaptured by standard RNA-seq. A cP end
of RNA molecules, consisting of the phosphate linkage between the 20- and 30-positions of
ribose, is mainly produced from RNA cleavage catalyzed by many endoribonucleases [4]. cP-
containing RNAs (cP-RNAs) are not just accumulated as non-functional degradation products
but have physiological roles in various biological processes. For example, Angiogenin (ANG),
an RNase A-superfamily endoribonuclease, cleaves the anticodon-loop of tRNAs upon stress
stimuli to produce functional tRNA halves known as tRNA-derived stress-induced RNAs (tiR-
NAs) [5]. The 50-tiRNAs, corresponding to the 50-tRNA halves, contain a cP at their 30-end
and promote the formation of stress granules, regulate translation, and trigger the cellular
stress responses and apoptosis in neurodevelopmental disorders [6,7,8,9]. In breast and pros-
tate cancer cells, sex hormone signaling pathways promote ANG-catalyzed tRNA cleavages,
generating a distinct class of tRNA halves, the sex hormone-dependent tRNA derived RNAs
(SHOT-RNAs) [10]. cP-containing 50-SHOT-RNAs (50-tRNA halves) have a functional signifi-
cance in cell proliferation [10,11].
Given that cP-RNAs are expressed as functional molecules, capturing the entire repertoire
of cP-RNAs would broaden the catalog of functional ncRNAs and reveal significant biological
events that have been eluding standard RNA-seq. We recently developed “cP-RNA-seq,”
which is able to specifically sequence cP-RNAs [10,12], and applied the method to a short
RNA fraction of BT-474 breast cancer cells to identify 50-SHOT-RNAs [10]. Because the previ-
ous work narrowly focused on 50-SHOT-RNAs in only one cell line, cP-RNAs still largely
remained a hidden component in the transcriptome. In this report, we expanded populations
of RNA subjects and identified a comprehensive repertoire of short cP-RNAs in four different
mouse tissues. A genome-wide in-depth view of cP-RNA transcriptome revealed that not only
tRNAs but also other RNA species are widely, but specifically, cleaved between cytidine and
adenosine for constitutive expression of diverse species of cP-RNAs. We further discovered
age-dependent changes in the expression levels of cP-RNAs, implying the involvement of
cP-RNA production in the aging process.
Genome-wide identification of short cP-RNAs
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Results and discussion
cP-containing tRNA halves are abundantly and constitutively expressed in
mouse tissues
Because ANG-generated 50-tRNA halves contain a cP, exploration of the accumulation of
cP-RNAs in mouse tissues began with analyses of tRNA halves. Northern blots for cyto-
plasmic (cyto) tRNALysCUU and tRNAAspGUC, both of which abundantly produce tRNA
halves in human breast cancer cells [10], revealed constitutive expression of both the 50- and
30-halves in various mouse tissues (Figs 1A and S1A). Although the levels of mature tRNAs
were comparable across all the examined tissues, tRNA halves showed differential expres-
sion patterns among the tissues, implying a regulated biogenesis of tRNA halves. The abun-
dant accumulation of 50-tRNA halves found in the spleen and less abundant accumulations
in other tissues, such as the brain, heart, liver, and testis, are consistent with previous
reports [13,14]. To confirm the presence of a cP in the 50-tRNA halves, total RNA from
mouse lungs was treated with T4 polynucleotide kinase (T4 PNK; removes 30-P/cP), calf
intestinal phosphatase (CIP; removes 50-P/30-P, but not a cP), or acid followed by CIP treat-
ment (removes 50-P/30-P/cP), and then the mobility of the bands of the 50-tRNA half was
Fig 1. Sequencing of cP-RNAs in mouse tissues. (A) Total RNAs extracted from mouse tissues were subjected to
northern blots for the 50-halves of cyto tRNALysCUU and tRNAAspGUC. (B) Terminal structures of the 50-tRNA half were
analyzed enzymatically. Total RNA from the mouse lung was treated with CIP, T4 PNK, or acid followed by CIP
treatment (HCl + CIP). NT designates the non-treated sample used as a negative control. The treated total RNA was
subjected to northern blots targeting the 50-tRNAAspGUC half and microRNA-16 (miR-16). miR-16 was investigated as a
control RNA containing 50-P and 30-OH ends. (C) Gel-purified 20–45-nt RNAs were subjected to cP-RNA-seq, which
amplified 140–160-bp cDNA products (50-adapter, 55 bp; 30-adapter, 63 bp; and thereby estimated inserted sequences,
22–42 bp). The cDNAs in the region designated with a red line were purified and subjected to Illumina sequencing. (D)
Proportion of cP-RNAs annotated to the indicated RNAs.
https://doi.org/10.1371/journal.pgen.1008469.g001
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examined by northern blots, as previously described [10,12]. As shown in Fig 1B, the band
of the 50-tRNA half shifted up by CIP treatment, suggesting the presence of a P in the 50-
tRNA half. T4 PNK treatment also shifted the band up, and further up-shift was observed
by the acid plus CIP treatments, indicating the additional presence of a cP in the 50-tRNA
half. These results validated that, as observed for the 50-tRNA halves in human cell lines
[10], the 50-tRNA halves in mouse tissues contain a P at their 50-end and a cP at their 30-end.
Selective amplification and sequencing of short cP-RNAs expressed in
mouse tissues
To capture an entire picture of short cP-RNAs, we selected four tissues (thymus, lung, spleen,
and skeletal muscle) that exhibited an abundant expression of 50-tRNA halves (Fig 1A). The
four tissues commonly showed accumulations of short RNAs that were expected to include
50-tRNA halves (S1B Fig), whereas we did not observe such short RNA accumulation in
HEK293T and HeLa cells (S1B Fig), implying that the constitutive accumulation of short RNAs
might be tissue specific. We chose to focus on the 20 to 45-nucleotide (nt) RNAs which were
gel-purified and subjected to cP-RNA-seq [10,12]. The method successfully amplified ~140 to
160-bp cDNA products (inserted sequences without adapters were estimated to be 22–42 bp)
whose dependency on T4 PNK treatment indicates that, as expected, the amplified bands were
derived from cP-RNAs (Fig 1C). Illumina sequencing of the amplified bands from the respec-
tive four tissues yielded approximately 38–47 million raw reads, of which>90%–97% were
extracted as the cP-RNA reads with a length of 20–45 nt (S1 Table). Read lengths of the
extracted cP-RNAs similarly showed broad distribution patterns in different tissues (S2 Fig).
Mapping the cP-RNA reads to the mouse ncRNAs and genome unexpectedly revealed that not
only tRNAs but also the other RNA species serve as abundant substrates for cP-RNA produc-
tion (Fig 1D). Although tRNA-derived reads were the most abundant cP-RNA species and
occupied a substantial proportion of cP-RNAs, ~55%–80% reads are mapped to other regions
of the genome, of which messenger RNAs (mRNAs) and ribosomal RNAs (rRNAs) were partic-
ularly rich sources of cP-RNAs (Fig 1D and S1 Table).
tRNA-derived cP-RNAs are generated from focal cleavage of anticodon-
loop and 30-terminal CCA sequence of tRNAs
tRNA-derived ncRNAs can be classified into 50-tRNA half, 30-tRNA half, 50-tRF, 30-tRF, and
internal-tRF (i-tRF) [15,16,17,18] (S3A Fig). tRNA-derived cP-RNAs were mostly 30–40 nt
long (S2 Fig) and the majority were 50-halves (Fig 2A) as expected. Considering that the
mouse genome encodes 55 cyto tRNA isoacceptors with different anticodon sequences [19],
the identified 50-halves were derived from a rather focused subset of tRNAs, such as cyto
tRNAValCAC, tRNAGlyGCC, tRNALysCUU, and tRNAGluCUC, which are in aggregates the sources
of 75%–84% of the identified 50-halves (Fig 2B). The 30-terminal nucleotides of the 50-halves
had a strongly biased composition in being pyrimidines (C >U), which was a stable property
in all four examined tissues (Fig 2C). The anticodon-loop nucleotides that are one position
downstream of the 30-end showed biases of A and U, allowing us to predict that the anticodon-
loop cleavage mainly occurs between C and A/U to produce cP-containing 50-halves (Figs 2C
and 2D and S3B).
Among all species of tRNAs, tRNAHisGUG is unique in that it contains an additional nucleo-
tide at nucleotide position (np; according to the nucleotide numbering system of tRNAs [20])
–1 of its 50-end. Our recent TaqMan RT-qPCR analyses revealed that, in BT-474 cells, the
majority (~60%) of cyto tRNAHisGUG contains G–1, but a significant proportion contains U–1
or lacks the –1 nucleotide, resulting in G1 as a 5
0-terminal nucleotide [21]. As shown in S3C
Genome-wide identification of short cP-RNAs
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Fig, a majority of the identified 50-halves of cyto tRNAHisGUG contained G–1, but the 5
0-halves
containing U–1 or lacking –1 nucleotide (G1) were also substantially detected, suggesting that
the presence of U–1 as well as G–1 is a conserved feature in mouse cyto tRNA
HisGUG, which is
retained in the identified 50-halves.
It was unexpected that a substantial proportion (9%–31%) of tRNA-derived cP-RNAs were
occupied by 30-halves. All three tRFs (50-, 30-, and i-tRFs) were identified as minor cP-contain-
ing species compared to the tRNA halves. When subclassified into the four subgroups (30-
CCA-/30-CC-/30-C-/30-Di-halves; S3A Fig), nearly all (89%–98%) of the identified 30-halves
were 30-CC-halves (Fig 2E and S2 Table), suggesting that the 30-terminal cP formation resulted
from the cleavage between C75 and A76 of tRNAs. The in vitro ANG-catalyzed cleavage between
C75 and A76 was previously reported [22], and our results might suggest the occurrence of cleav-
age in vivo. The 30-CC- and 30-C-halves were identified as cP-RNAs also in human brain [23],
suggesting the consistency between mouse and human tissues. The anticodon-loop cleavage
sites predicted by the 30-terminal position of the 50-halves and the 50-terminal position of the
30-halves were sometimes consistent (Figs 2D and S3B). Therefore, specific tRNAs are likely to
Fig 2. Analyses of tRNA-derived cP-RNAs. (A) Proportion of tRNA-derived cP-RNAs classified into the indicated
subgroups of tRNA-derived ncRNAs shown in S3A Fig. (B) Proportion of the 50-half-reads derived from respective
cyto tRNA species. (C) Compositions of the 30-terminal nucleotide of the 50-halves and its 30-adjacent nucleotide
(potential 50-terminal nucleotide of the 50-cleavage product) in the anticodon-loop of tRNAs. (D) Cleavage sites in the
anticodon-loops in the thymus were predicted based on the 30-terminal positions of the 50-halves (blue arrow heads)
and the 50-terminal positions of the 30-halves (red arrow heads). The results for the other three tissues are shown in
S3B Fig. (E) Proportion of the 30-halves classified into the indicated subgroups shown in S3A Fig. The numerical data
is shown in S2 Table.
https://doi.org/10.1371/journal.pgen.1008469.g002
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be selected for cP-RNA production and at least some of their 50- and 30-half pairs could be con-
currently produced by endonucleolytic cleavage at the anticodon-loops.
mRNA-derived cP-RNAs are produced from a specific processing between
adenine and cytosine
Although not anticipated, not only tRNAs but also other RNA species were identified as rich
sources of cP-RNAs. mRNA-derived cP-RNAs were enriched in cP-RNA libraries from all
four examined tissues, accounting for 15%–20% of all cP-RNA species (Fig 1D). The lengths
of the mRNA-derived cP-RNAs were broadly distributed between 20–45 nt (S2 Fig). Both cod-
ing and untranslated regions of mRNAs became substrates for cP-RNAs (S4A Fig). Astonish-
ing nucleotide composition biases were observed at both the 50- and 30-ends of mRNA-derived
cP-RNAs in all four tissues (Figs 3A and S4B). The 50-ends were mostly A (78%–89%),
whereas the 30-ends were mostly pyrimidines, and C (70%–81%) was especially enriched com-
pared to U (17%–29%). None of the biases were observed in the nucleotides from the second
position to the position preceding the 30-ends. The nucleotides that are one position upstream
of the 50-ends and one position downstream of the 30-ends showed clear A and C biases (Fig
3B), strongly suggesting that the mRNA-derived cP-RNAs are produced by an endoribonu-
clease that specifically recognizes and cleaves mRNAs between C and A residues.
Major mRNA species producing cP-RNAs are not very consistent among different tissues
(S3 Table), and the cP-RNAs were derived from many different regions throughout the
mRNAs (S4C Fig). In the spleen, many abundant cP-RNAs were derived from hemoglobin
mRNAs, which might be correlated to the role of the spleen in red blood cell turnover that
requires the degradation of hemoglobin [24]. It should be noted that some mRNAs, such as
Hist1h2br and B2m in the thymus (S4C Fig), showed very focal production of specific
cP-RNAs, suggesting that the cP-RNA production and accumulation are not caused by ran-
dom mRNA degradation. The most prominent example is Ncbp3 mRNA which commonly
produces the most abundant mRNA-derived cP-RNA in all four tissues (S3 Table). Although
there are 406 “CA” sequences (potential cleavage sites) throughout Ncbp3 mRNAs, almost all
cP-RNAs are produced from only one site (position 5780–5809; the generated cP-RNA is
termed cPR-Ncbp3) in the 30-UTR (Fig 4A), where single-stranded loop regions are expected
to be formed (Fig 4B). The common and specific production of cP-RNAs might suggest that
these RNAs are produced as functional molecules.
cP-RNAs produced from other RNA species are also produced from a
specific processing between adenine and cytosine
rRNA-derived cP-RNAs, whose read lengths were broadly distributed between 20–45 nt (S2 Fig),
were enriched at similar levels (15%–25% of all cP-RNA species; Fig 1D) with mRNA-derived
cP-RNAs. All four rRNA species (28S, 18S, 5.8S, and 5S) produce cP-RNAs (S5A Fig), and the
most abundant cP-RNA species were derived from 28S rRNA (S4 Table). Nucleotide biases
observed in mRNA-derived cP-RNAs were retained mostly in rRNA-derived cP-RNAs; the 30-
end and a nucleotide upstream of the 50-end were strongly biased to C and U (C> U) (Fig 3C).
The 50-end and a nucleotide downstream of the 30-end were not only biased to A, but also to G,
and sometimes to U. Alignment visualization showed production of specific cP-RNA species from
rRNAs (Figs 4A and S5B), suggesting their controlled biogenesis mechanisms. In 28S rRNA, the
positions 186–217 was the most abundant cP-RNA-producing region (Fig 4A), and the represen-
tative cP-RNA from the region, termed cPR-28S, is produced from the cleavages between C185
and G186, and C217 and A218 in domain 1 (Fig 4B). Cleavage positions reside in the loop regions of
28S rRNA, possibly because the regions are highly accessible to endoribonucleases.
Genome-wide identification of short cP-RNAs
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cP-RNAs from small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs), microRNAs
(miRNAs), and long ncRNAs (lncRNAs) showed terminal nucleotide bias to A and C for their 50-
and 30-end, respectively, in all four tissues (S6 and S7 Figs). Moreover, not only the cP-RNAs
derived from the nuclear genome but also the cP-RNAs derived from the mitochondrial genome
showed similar nucleotide biases (S8 Fig). Although those cP-RNAs were not abundant, the con-
sistent nucleotide biases suggest that cP-RNAs are produced from a wide variety of RNA species
through identical RNA processing events mainly between cytidine and adenosine.
The identified cP-RNAs are abundantly accumulated in mouse tissues
To biochemically validate that the identified sequences are expressed as cP-RNAs, we focused
on the three representative cP-RNAs, 50-half of tRNAGlyGCC (50-GlyGCC), cPR-Ncbp3, and
cPR-28S (Fig 4B), which are one of the most abundantly sequenced species among tRNA-,
Fig 3. Nucleotide composition analyses of mRNA- and rRNA-derived cP-RNAs. (A) Nucleotide compositions of
the first 30 nucleotides from the 50-end (upper) or 30-end (lower) of the mRNA-derived cP-RNAs in the thymus and
lung. The results for the other two tissues are shown in S4B Fig. (B) Nucleotide compositions around the 50- and 30-
ends of mRNA-derived cP-RNAs. A dashed line separates upstream (-) and downstream (+) positions for the 50-and
30-ends, representing the cleavage site that generates mRNA-derived cP-RNAs (the regions outside of cP-RNA-
generating regions are colored in grey). (C) Nucleotide compositions around the 50- and 30-ends of rRNA-derived
cP-RNAs.
https://doi.org/10.1371/journal.pgen.1008469.g003
Genome-wide identification of short cP-RNAs
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mRNA-, and rRNA-derived cP-RNAs, respectively. To analyze 30-terminal structures of the
three species, total RNA from mouse skeletal muscle was treated with CIP or T4 PNK. A
mutant T4 PNK, which lacks 30-dephosphorylation activity [25], was also used as a control.
Subsequently, efficiency of the ligations between each target RNA and a 30-adapter was exam-
ined by TaqMan RT-qPCR as described in [26]. As shown in Fig 4C, all three target RNAs
exhibited the highest amplification signals upon T4 PNK treatment, indicating that the major
30-terminal form of the identified sequences are a cP. CIP treatment showed certain signal lev-
els, suggesting co-expression of 30-P-containing RNAs as a minor form or occurrence of
hydrolysis reaction converting a cP to a P during experimental procedures.
Using their specific quantification by TaqMan RT-qPCR, we explored absolute amounts of
the three cP-RNAs expressed in mouse lung and skeletal muscle. The calculation of the
amounts was based on the standard curve from synthetic RNAs which showed excellent
Fig 4. TaqMan RT-qPCR quantification of cP-RNAs. (A) The alignment patterns of cP-RNAs for Ncbp3 mRNA and
28S rRNA. The positions of representative cP-RNAs, cPR-Ncbp3 and cPR-28S, are indicated. (B) The regions from
which 50-tRNAGlyGCC half (50-GlyGCC), cPR-Ncbp3, and cPR-28S were derived are shown in red in the secondary
structure of respective substrate RNAs. Secondary structure of Ncbp3 mRNA was predicted by ViennaRNA Package
2.0 [34]. (C) The total RNA from 24-week old mouse skeletal muscle, treated with CIP, wild-type (WT) T4 PNK, or
mutant (Mut) T4 PNK lacking 30-dephosphorylation activity, was subjected to TaqMan RT-qPCR. NT designates a
non-treated sample used as a negative control. The amounts from WT T4 PNK-treated RNA were set as 1, and relative
amounts are indicated. Averages of three experiments with SD values are shown. (D) The expression of cP-RNAs in
the lung and skeletal muscle of 24-week old mice were quantified using TaqMan RT-qPCR. The cP-RNA amounts
were estimated based on the standard curves shown in S9 Fig. Averages of three independent experiments with SD
values are shown.
https://doi.org/10.1371/journal.pgen.1008469.g004
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linearity between input amounts and amplification signals (S9 Fig). The determined abun-
dances of the three cP-RNAs per 1 μg of total RNA were summarized in Fig 4D. Whereas the
amounts of 50-GlyGCC and cPR-Ncbp3 were comparable between lung and muscle, the
amount of cPR-28S in lung is ~14-fold higher than that in muscle. Considering previous
reports estimating that 1 μg of total RNA from mouse liver contains 0.005–8.8 fmol of miRNA
[27], the accumulation of cP-RNAs in mouse tissues are estimated to be much more abundant
than that of miRNAs.
Age-dependent decrease in the expression levels of cP-RNAs
To explore physiological relevance of cP-RNA expression, TaqMan RT-qPCR quantification
of the three cP-RNAs were performed for skeletal muscle of mice with four different ages, 2,
12, 24, and 84 weeks. While a control U6 snRNA showed consistent expression levels in all the
examined mice, the expression levels of all three cP-RNAs were reduced along with aging, and
the differences between 2- and 84-week old mice were especially apparent (Fig 5A). The
cP-RNA levels in 12- and 24-week old mice, both of which are considered as adult mice, did
not show a significant change between them and were in-between those of 2- and 84-week old
mice. To ask whether the phenomenon is conserved in different tissues, we further investi-
gated lung of mice with different ages, showing the reduction of the expression levels of all
three cP-RNAs through aging (Fig 5B). Total RNA staining pattern further suggested global
reduction of the expression of 30–45-nt short ncRNAs, which are expected to contain
cP-RNAs, through aging (Fig 5C).
To investigate potential relationship between cP-RNAs and their substrate RNAs in expres-
sional regulation through aging, we focused on mRNA-derived cP-RNAs. Total RNAs from
lung of 2- and 84-week old mice were subjected to cP-RNA-seq and mRNA-seq for identifica-
tion of mRNA-derived cP-RNAs and their substrate mRNAs, respectively. Consistent with the
downregulated expression of cP-RNAs in older mice (Fig 5A–5C), cP-RNA-seq amplified less
abundant cDNAs from the 84-week old mice compared to the 2-week old mice (Fig 5D). Illu-
mina sequencing of the cDNAs yielded ~23–29 million raw reads, of which ~3–6.5 million
reads were extracted as the reads of mRNA-derived cP-RNAs (S5 Table). After normalization
based on the read number information of a spike-in cP-RNA, fold changes of cP-RNA read
numbers of 84 week samples, with respect to those of 2 week samples, were compared with
fold changes of mRNA-seq read numbers for each mRNA in a scatter plot (Fig 5E). Strong
aggregations of the spots appeared at the point where the levels of cP-RNAs were 4-fold
reduced in 84-week samples compared to 2-week samples without changes in the levels of
their substrate mRNAs. Consistent with the results of TaqMan RT-qPCR (Fig 5A and 5B),
reduction of cPR-Ncbp3 was confirmed in the scatter plot (Fig 5E). As representative results,
normalized alignment patterns of cP-RNAs in the three selected mRNAs, Ncbp3, Cd93, and
Tsc22d1, are shown in Fig 5F. Specific productions of cP-RNAs through cleavage between C
and A residues and their reduction in 84-week samples were observed. Together with the
decreased C and A nucleotide biases in 84-week samples (S10 Fig), these results suggest that
the expression of cP-RNAs is decreased through aging, which is independent of the levels of
substrate RNAs but is caused by reduced C-A cleavage activity for cP-RNA productions or by
reduced stability of cP-RNAs.
Conclusion
In this study, we unraveled a previously hidden layer of transcriptome by comprehensively
identifying short cP-RNA species expressed in mouse tissues. Each cP-RNA library, obtained
by cP-RNA-seq, commonly comprised previously uninterrogated cP-RNA species that are
Genome-wide identification of short cP-RNAs
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008469 November 13, 2019 9 / 15
Fig 5. Expression of cP-RNAs in tissues from mice with different ages. (A) Total RNAs from skeletal muscle of 2–84-week old mice were subjected to
TaqMan RT-qPCR for quantification of the indicated cP-RNAs. U6 snRNA was quantified as the control whose expression is unchanged through aging.
��P< 0.01, ���P< 0.001 by t-test. (B) Total RNAs from lung of 2–84-week old mice were subjected to cP-RNA quantification. (C) Total RNAs from the
biological duplicates of lung from 2- and 84-week old mice were subjected to denaturing PAGE and stained by SYBR Gold. The RNAs in the region
designated with a red line were purified and subjected to cP-RNA-seq. (D) cDNAs amplified by cP-RNA-seq. (E) A scatter plot representing the fold
changes of the read numbers for each mRNA in 84-week samples, with respect to those in 2-week samples, from cP-RNA-seq (y-axis) and mRNA-seq (x-
axis). The plots of the three mRNAs, whose alignment patterns are shown in Fig 5F, are highlighted. (F) The alignment patterns of cP-RNAs for Ncbp3,
Cd93, and Tsc22d1 mRNAs. The viewer height in each panel was adjusted based on the normalization by the reads of a spike-in cP-RNA.
https://doi.org/10.1371/journal.pgen.1008469.g005
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expected to be generated by specific RNA cleavage between cytidine and adenosine (S11 Fig).
The endoribonuclease generating the identified cP-RNAs is unknown but should possess
highly specific recognition and cleavage activity for the 50-CA-30 sequence. ANG might be the
candidate enzyme because ANG produces cP-RNAs [10,28] and shows the highest activity
toward the 50-CA-30 among four examined dinucleotides in a previous study [29]. Among
other cP-generating ribonucleases, GCN4 shows high cleavage activity between C and A [30].
Because cP-RNAs are not evenly produced from overall sequences of substrate RNAs but
rather derived from specific sites, the RNA cleavage activity to generate cP-RNAs might be
exquisitely regulated. Further investigations are required to clarify the enzyme and its activity
for the generation of the cP-RNAs identified in this study. Considering the already-proven
functional significance of tRNA-derived cP-RNAs [6,7,8,9,10], it is not surprising that the
identified cP-RNAs themselves have functional significance. Their abundance and expression
from only specific sites of substrate RNAs might also imply their expression as functional mol-
ecules. The reduction of cP-RNA generation through aging implied its physiological relevance.
It will be intriguing to examine further the cellular factors that influence, or are influenced by,
the expression of cP-RNAs and their underlying molecular mechanisms, which will define
cP-RNAs as an abundant class of functional non-coding RNAs.
Materials and methods
Ethics statement
All mouse experiments were conducted in compliance with the standards and guidelines of
the National Institutes of Health (NIH) and were approved by the Institutional Animal Care
and Use Committee at Thomas Jefferson University. Mice were euthanized by CO2 inhalation
followed by tissue dissections.
RNA isolation and enzymatic treatment
For cP-RNA-seq, tissues of thymus, lung, spleen, and skeletal muscle from hindlimbs were dis-
sected from male C57BL/6J (B6) mice at approximately 3-months ages. The dissected tissues
were homogenized in TRIsure (Bioline) using a glass homogenizer on ice, after which total
RNA was extracted according to the manufacturer’s instruction. For TaqMan RT-qPCR, fro-
zen tissues were crushed using a frozen mortar and a pestle, followed by total RNA extraction
by TRIsure. To investigate the terminal structures of the 50-tRNA half, total RNA was treated
with CIP (New England Biolabs), T4 PNK (New England Biolabs), or acid (incubation in 10
mM HCl at 4˚C for 3 h) followed by CIP treatment as previously described [10,12].
Northern blot
Northern blot was performed as previously described [31] with the following antisense probes:
50-tRNALysCUU half, 50- GTCTCATGCTCTACCGACTG-30; 30-tRNALysCUU half, 50-GCTC
GAACCCACGACCCTGAGA-30; 50-tRNAAspGUC half, 50-GGGATACTCACCACTATACT
AACGAGGA-30; 30-tRNAAspGUC half, 50- GAATCGAACCCCGGTCTCC-3; and miR-16,
50-GCCAATATTTACGTGCTGCTA-30.
cP-RNA-seq
For four tissue samples (thymus, lung, spleen, and skeletal muscle), 20 to 45-nt RNAs were
gel-purified from total RNA and subjected to cP-RNA-seq procedure as previously described
[10,12]. The amplified cDNAs were gel-purified and sequenced using the Illumina HiSeq 2500
system at the Next-Generation Sequencing Core of the University of Pennsylvania.
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For comparison between 2- and 84-week old mice, lung 20–45-nt RNAs were gel-purified
together with a synthetic spike-in cP-RNA (50-CAGUGGUGGGCCAGAUGUAAACAUUA-
GAUUGUUCUUG-cP-30, synthesized by ChemGenes). cDNAs amplified by cP-RNA-seq
procedure were sequenced using Illumina NextSeq 500 at the MetaOmics Core of Sidney Kim-
mel Cancer Center in Thomas Jefferson University.
Bioinformatics analyses
The cP-RNA-seq libraries contain ~22–47 million raw reads (S1 and S5 Tables) and are publi-
cally available at NCBI’s Sequence Read Archive (accession No. SRR8164560, SRR8164561,
SRR8164562, SRR8164563, SRR9651811, SRR9651812, SRR9651813, and SRR9651814). Before
mapping, we used the cutadapt tool (DOI: http://dx.doi.org/10.14806/ej.17.1.200) to remove
the 30-adapter sequence. After selecting 20–45-nt reads, we used Rbowtie (1.15.1) [32] for the
sequential mappings with one mismatch allowed. The reads were first mapped to 471 mature
cyto tRNAs obtained from GtRNAdb [19], and then to mature rRNAs, to mitochondrial
genome (GenBank DQ106412 sequence plus 22 mitochondrial tRNA sequences), to mRNAs
of RefSeq with NM-staring accession numbers, and to whole genome. All the sequences and
annotations, except for the mitochondrial genome, were derived from the Mus musculus
GRCm38 (mm10) genome assembly. Nucleotide compositions were analyzed by running
FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). For the nucleotide
composition analyses of the sequences which are upstream or downstream of cP-RNA produc-
ing regions on the genome, 4-nt upstream/downstream sequences were retrieved by referring
fasta files and subjected to FastQC analyses. The Integrative Genomics Viewer (IGV) [33] was
used for visualizing the aligned reads.
For comparison between 2- and 84-week samples, the extracted 20–45-nt cP-RNA reads were
first mapped to the sequence of the spike-in cP-RNA, followed by the sequential mappings as
described above. The read numbers of the spike-in cP-RNA were used to calculate the normalized
RPKM of each cP-RNA-producing mRNA. mRNA-seq was performed by Novogene and RPKM
of each mRNA was also obtained. These RPKM values were used for calculations of fold-changes
of 84-week samples, with respect to 2-week samples, and the values derived from cP-RNA-seq
and mRNA-seq were compared in the scatter plot. The experiments of cP-RNA-seq and mRNA-
seq were performed using biological duplicates and triplicates, respectively.
Quantification of cP-RNAs by TaqMan RT-qPCR
TaqMan RT-qPCR for specific quantification of cP-RNAs was performed as previously
described [10]. Briefly, to remove a cP from cP-RNAs, total RNA was treated with T4 PNK,
followed by ligation to a 30-RNA adapter by T4 RNA ligase. Ligated RNA was then subjected
to TaqMan RT-qPCR using the One Step PrimeScript RT-PCR Kit (TaKaRa), 200 nM of a
TaqMan probe targeting the boundary of the target RNA and 30-adapter, and specific forward
and reverse primers. The quantified cP-RNA levels were normalized to 5S rRNA levels. The
sequences of the TaqMan probes and primers are shown in S6 Table. For the quantification of
absolute amounts of cP-RNAs, each synthetic RNA was mixed with 1 μg of E. coli total RNA
and the mixtures were used as the substrates to obtain standard curves shown in S9 Fig. In Fig
5A and 5B, Student’s t-tests were used to evaluate the differences between 2- and 84-week
samples.
Supporting information
S1 Fig. RNAs of mouse tissues.
(EPS)
Genome-wide identification of short cP-RNAs
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008469 November 13, 2019 12 / 15
S2 Fig. Read-length distributions of cP-RNA sequences obtained by cP-RNA-seq.
(EPS)
S3 Fig. Analyses of tRNA-derived cP-RNAs.
(EPS)
S4 Fig. Analyses of mRNA-derived cP-RNAs.
(EPS)
S5 Fig. Analyses of rRNA-derived cP-RNAs.
(EPS)
S6 Fig. 50- and 30-terminal nucleotide compositions of the cP-RNAs derived from snRNAs,
snoRNAs, miRNAs, and lncRNAs.
(EPS)
S7 Fig. Nucleotide compositions of the first 30 nucleotides from the 50-end or the 30-end of
the lncRNA-derived cP-RNAs.
(EPS)
S8 Fig. Analyses of mitochondrial cP-RNAs.
(EPS)
S9 Fig. Standard curves for the quantification of cP-RNAs.
(EPS)
S10 Fig. Nucleotide composition analyses of mRNA-derived cP-RNAs.
(EPS)
S11 Fig. Schematic representation of the generation of cP-RNAs and its age-dependent
changes.
(EPS)
S1 Table. Read numbers of cP-RNA libraries obtained from cP-RNA-seq for four mouse
tissues.
(XLSX)
S2 Table. Proportion of the 30-halves (%).
(XLSX)
S3 Table. Top 50 reads of mRNA-derived cP-RNAs.
(XLSX)
S4 Table. Top 50 reads of rRNA-derived cP-RNAs.
(XLSX)
S5 Table. Read numbers of cP-RNA libraries obtained from cP-RNA-seq for lung of 2 and
84 week-old mice.
(XLSX)
S6 Table. Sequences of TaqMan probes and primers for RT-qPCR.
(XLSX)
Acknowledgments
We are grateful to Dr. Isidore Rigoutsos and the members of Kirino lab for helpful discussions.
Genome-wide identification of short cP-RNAs
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008469 November 13, 2019 13 / 15
Author Contributions
Conceptualization: Yohei Kirino.
Data curation: Megumi Shigematsu, Yohei Kirino.
Funding acquisition: Yohei Kirino.
Investigation: Megumi Shigematsu, Keisuke Morichika, Takuya Kawamura, Shozo Honda.
Methodology: Megumi Shigematsu, Keisuke Morichika, Shozo Honda, Yohei Kirino.
Project administration: Megumi Shigematsu.
Supervision: Yohei Kirino.
Validation: Megumi Shigematsu, Takuya Kawamura.
Visualization: Megumi Shigematsu, Yohei Kirino.
Writing – original draft: Megumi Shigematsu, Yohei Kirino.
Writing – review & editing: Yohei Kirino.
References
1. Goodwin S, McPherson JD, McCombie WR (2016) Coming of age: ten years of next-generation
sequencing technologies. Nat Rev Genet 17: 333–351. https://doi.org/10.1038/nrg.2016.49 PMID:
27184599
2. Marguerat S, Bahler J (2010) RNA-seq: from technology to biology. Cell Mol Life Sci 67: 569–579.
https://doi.org/10.1007/s00018-009-0180-6 PMID: 19859660
3. Costa V, Aprile M, Esposito R, Ciccodicola A (2013) RNA-Seq and human complex diseases: recent
accomplishments and future perspectives. Eur J Hum Genet 21: 134–142. https://doi.org/10.1038/
ejhg.2012.129 PMID: 22739340
4. Shigematsu M, Kawamura T, Kirino Y (2018) Generation of 2’,3’-Cyclic Phosphate-Containing RNAs as
a Hidden Layer of the Transcriptome. Front Genet 9: 562. https://doi.org/10.3389/fgene.2018.00562
PMID: 30538719
5. Yamasaki S, Ivanov P, Hu GF, Anderson P (2009) Angiogenin cleaves tRNA and promotes stress-
induced translational repression. J Cell Biol 185: 35–42. https://doi.org/10.1083/jcb.200811106 PMID:
19332886
6. Emara MM, Ivanov P, Hickman T, Dawra N, Tisdale S, et al. (2010) Angiogenin-induced tRNA-derived
stress-induced RNAs promote stress-induced stress granule assembly. J Biol Chem 285: 10959–
10968. https://doi.org/10.1074/jbc.M109.077560 PMID: 20129916
7. Ivanov P, Emara MM, Villén J, Gygi SP, Anderson P (2011) Angiogenin-Induced tRNA Fragments
Inhibit Translation Initiation. Molecular Cell 43: 613–623. https://doi.org/10.1016/j.molcel.2011.06.022
PMID: 21855800
8. Ivanov P, O’Day E, Emara MM, Wagner G, Lieberman J, et al. (2014) G-quadruplex structures contrib-
ute to the neuroprotective effects of angiogenin-induced tRNA fragments. Proc Natl Acad Sci U S A
111: 18201–18206. https://doi.org/10.1073/pnas.1407361111 PMID: 25404306
9. Blanco S, Dietmann S, Flores JV, Hussain S, Kutter C, et al. (2014) Aberrant methylation of tRNAs links
cellular stress to neuro-developmental disorders. EMBO J 33: 2020–2039. https://doi.org/10.15252/
embj.201489282 PMID: 25063673
10. Honda S, Loher P, Shigematsu M, Palazzo JP, Suzuki R, et al. (2015) Sex hormone-dependent tRNA
halves enhance cell proliferation in breast and prostate cancers. Proc Natl Acad Sci U S A 112: E3816–
3825. https://doi.org/10.1073/pnas.1510077112 PMID: 26124144
11. Honda S, Kirino Y. (2015) SHOT-RNAs: a novel class of tRNA-derived functional RNAs expressed in
hormone-dependent cancers. Mol Cell Oncol 3: e1079672. https://doi.org/10.1080/23723556.2015.
1079672 PMID: 27308603
12. Honda S, Morichika K, Kirino Y (2016) Selective amplification and sequencing of cyclic phosphate-con-
taining RNAs by the cP-RNA-seq method. Nat Protoc 11: 476–489. https://doi.org/10.1038/nprot.2016.
025 PMID: 26866791
Genome-wide identification of short cP-RNAs
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008469 November 13, 2019 14 / 15
13. Dhahbi JM, Spindler SR, Atamna H, Yamakawa A, Boffelli D, et al. (2013) 5’ tRNA halves are present
as abundant complexes in serum, concentrated in blood cells, and modulated by aging and calorie
restriction. BMC Genomics 14: 298. https://doi.org/10.1186/1471-2164-14-298 PMID: 23638709
14. Sharma U, Conine CC, Shea JM, Boskovic A, Derr AG, et al. (2016) Biogenesis and function of tRNA
fragments during sperm maturation and fertilization in mammals. Science 351: 391–396. https://doi.
org/10.1126/science.aad6780 PMID: 26721685
15. Shigematsu M, Honda S, Kirino Y (2014) Transfer RNA as a source of small functional RNA. J Mol Biol
Mol Imaging 1. PMID: 26389128
16. Loher P, Telonis AG, Rigoutsos I (2017) MINTmap: fast and exhaustive profiling of nuclear and mito-
chondrial tRNA fragments from short RNA-seq data. Sci Rep 7: 41184. https://doi.org/10.1038/
srep41184 PMID: 28220888
17. Pliatsika V, Loher P, Telonis AG, Rigoutsos I (2016) MINTbase: a framework for the interactive explora-
tion of mitochondrial and nuclear tRNA fragments. Bioinformatics 32: 2481–2489. https://doi.org/10.
1093/bioinformatics/btw194 PMID: 27153631
18. Telonis AG, Loher P, Honda S, Jing Y, Palazzo J, et al. (2015) Dissecting tRNA-derived fragment com-
plexities using personalized transcriptomes reveals novel fragment classes and unexpected dependen-
cies. Oncotarget 6: 24797–24822. https://doi.org/10.18632/oncotarget.4695 PMID: 26325506
19. Chan PP, Lowe TM (2009) GtRNAdb: a database of transfer RNA genes detected in genomic
sequence. Nucleic Acids Res 37: D93–97. https://doi.org/10.1093/nar/gkn787 PMID: 18984615
20. Sprinzl M, Horn C, Brown M, Ioudovitch A, Steinberg S (1998) Compilation of tRNA sequences and
sequences of tRNA genes. Nucleic Acids Res 26: 148–153. https://doi.org/10.1093/nar/26.1.148
PMID: 9399820
21. Shigematsu M, Kirino Y (2017) 5’-Terminal nucleotide variations in human cytoplasmic tRNAHisGUG
and its 5’-halves. RNA 23: 161–168. https://doi.org/10.1261/rna.058024.116 PMID: 27879434
22. Czech A, Wende S, Mörl M, Pan T, Ignatova Z (2013) Reversible and rapid transfer-RNA deactivation
as a mechanism of translational repression in stress. PLoS Genet 9: e1003767. https://doi.org/10.
1371/journal.pgen.1003767 PMID: 24009533
23. Schutz K, Hesselberth JR, Fields S (2010) Capture and sequence analysis of RNAs with terminal 2’,3’-
cyclic phosphates. RNA 16: 621–631. https://doi.org/10.1261/rna.1934910 PMID: 20075163
24. Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5: 606–616. https://
doi.org/10.1038/nri1669 PMID: 16056254
25. Wang LK, Shuman S (2002) Mutational analysis defines the 5’-kinase and 3’-phosphatase active sites
of T4 polynucleotide kinase. Nucleic Acids Res 30: 1073–1080. https://doi.org/10.1093/nar/30.4.1073
PMID: 11842120
26. Honda S, Kawamura T, Loher P, Morichika K, Rigoutsos I, et al. (2017) The biogenesis pathway of
tRNA-derived piRNAs in Bombyx germ cells. Nucleic Acids Res 45: 9108–9120. https://doi.org/10.
1093/nar/gkx537 PMID: 28645172
27. Bissels U, Wild S, Tomiuk S, Holste A, Hafner M, et al. (2009) Absolute quantification of microRNAs by
using a universal reference. RNA 15: 2375–2384. https://doi.org/10.1261/rna.1754109 PMID: 19861428
28. Shapiro R, Riordan JF, Vallee BL (1986) Characteristic ribonucleolytic activity of human angiogenin.
Biochemistry 25: 3527–3532. https://doi.org/10.1021/bi00360a008 PMID: 2424496
29. Harper JW, Vallee BL (1989) A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond
generated by regional mutagenesis. Biochemistry 28: 1875–1884. https://doi.org/10.1021/
bi00430a067 PMID: 2719939
30. Nikolaev Y, Deillon C, Hoffmann SR, Bigler L, Friess S, et al. (2010) The leucine zipper domains of the
transcription factors GCN4 and c-Jun have ribonuclease activity. PLoS One 5: e10765. https://doi.org/
10.1371/journal.pone.0010765 PMID: 20505831
31. Honda S, Kirino Y, Maragkakis M, Alexiou P, Ohtaki A, et al. (2013) Mitochondrial protein BmPAPI mod-
ulates the length of mature piRNAs. RNA 19: 1405–1418. https://doi.org/10.1261/rna.040428.113
PMID: 23970546
32. Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-efficient alignment of short
DNA sequences to the human genome. Genome Biol 10: R25. https://doi.org/10.1186/gb-2009-10-3-
r25 PMID: 19261174
33. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, et al. (2011) Integrative genomics
viewer. Nat Biotechnol 29: 24–26. https://doi.org/10.1038/nbt.1754 PMID: 21221095
34. Lorenz R, Bernhart SH, Honer Zu Siederdissen C, Tafer H, Flamm C, et al. (2011) ViennaRNA Package
2.0. Algorithms Mol Biol 6: 26. https://doi.org/10.1186/1748-7188-6-26 PMID: 22115189
Genome-wide identification of short cP-RNAs
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008469 November 13, 2019 15 / 15
